Literature DB >> 32270882

False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence.

Ai Tang Xiao1, Yi Xin Tong1, Sheng Zhang1.   

Abstract

Entities:  

Keywords:  SARS coronavirus (virus classification); coronavirus (virus classification); shedding (pathogenesis)

Mesh:

Substances:

Year:  2020        PMID: 32270882      PMCID: PMC7262304          DOI: 10.1002/jmv.25855

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   20.693


× No keyword cloud information.

ETHICS STATEMENT

This study was approved by the Ethics committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. All procedures followed in this study were in accordance with the 1964 Helsinki Declaration and later versions. Oral consent was obtained from patients involved before enrollment when data were collected retrospectively. Dear Editor, A novel coronavirus disease (COVID‐19) pandemic caused by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) threatens the world. We read with interest the recent report by Li et al that included 610 patients with COVID‐19. They reported a high false‐negative rate of real‐time reverse transcription‐polymerase chain reaction (RT‐PCR) results for SARS‐CoV‐2 detection. In addition, a recent report regarding SARS‐CoV‐2 “turn positive” in recovered cases with COVID‐19 was published. Here, we studied the characteristics of nucleic acid conversion for SARS‐CoV‐2 from 70 COVID‐19 patients. We found that 15 (21.4%) patients experienced a “turn positive” of nucleic acid detection by RT‐PCR test for SARS‐CoV‐2 after two consecutive negative results, which may be related to the false negative of RT‐PCR test and prolonged nucleic acid conversion. A total of 70 patients (admission date from 21 January to 12 Febuary 2020) with confirmed SARS‐CoV‐2 infection at Tongji Hospital in Wuhan were included in this study. Throat swab samples or deep nasal cavity swab samples were collected from patients on different dates after the onset of symptoms. SARS‐CoV‐2 was detected by RT‐PCR assay using a COVID‐19 Nucleic Acid Detection Kit according to the manufacturer's protocol (Shanghai Huirui Biotechnology Co, Ltd). According to the current guideline, all included patients were mild to moderate. No patient was transferred to the intensive care unit. Nucleic acid conversion time is defined as the period from the date of symptoms onset to the date of first‐negative RT‐PCR test result (in some cases, patients got positive RT‐PCR results following false‐negative results, which were considered noneffective negative results in this study). Our results showed that 15 (21.4%) patients had a positive test result of RT‐PCR after two consecutive negative results. Compared to patients with two consecutive false‐negative RT‐PCR results, patients in the control group were more likely to be younger (P = .093) and had significantly shorter nucleic acid conversion time (21 vs 36 days; P < .001) (Table 1). Details of RT‐PCR test results were shown in Table S1. One patient (patient no. 5) has a positive test result of RT‐PCR for SARS‐CoV‐2 on 45 days after symptoms onset.
Table 1

The demographic and clinical characteristics of patients with COVID‐19

VariablesAll patients (N = 70)Nonconsecutive false negative (n = 55)Consecutive false negative (n = 15) P value
Age, median (IQR), y57 (44‐65)57 (43‐65)64 (51‐73).093
Sex, male, n (%)31 (44.3%)22 (40.0%)9 (60.0%).172
Severity on admission.935
Moderate66 (94.3%)52 (94.5%)14 (93.3%)
Severe4 (5.7%)3 (5.5%)1 (6.7%)
Onset of symptom to nucleic acid conversion, median (IQR), d22 (19‐32)21 (18‐26)36 (28‐40) <.001

Note: For P value: The boldface type indicates a significant difference.

Abbreviations: COVID‐19, coronavirus disease 2019; IQR, interquartile range.

The demographic and clinical characteristics of patients with COVID‐19 Note: For P value: The boldface type indicates a significant difference. Abbreviations: COVID‐19, coronavirus disease 2019; IQR, interquartile range. The pandemic of COVID‐19 threatened the whole world with more than 1 000 000 infected cases. Evidence suggested that the outbreaks of COVID‐19 may be correlated to its rapid person‐to‐person transmission ability. Since specific treatment had not been validated for COVID‐19, traditional public health tactics—isolation, quarantine, and community containment are critical to control the spread. , Another recent report by Lan et al found positive RT‐PCR test in cases of recovered patients with COVID‐19. According to our result, a certain number of COVID‐19 patients may experience a prolonged nucleic acid conversion regardless of the relief in symptoms or radiography. Current guideline suggested two consecutive negative RT‐PCR test results is one of the criteria for discharge. However, due to the high false‐negative rate of viral test and underestimated proportion of patients with prolonged nucleic acid conversion, the above patients may experience from false‐negative RT‐PCR results or prolonged viral clearance rather than “turn positive” or “recurrence.” Traces of virus detected by RT‐PCR were not necessarily correlated with the ability of transmission. However, a longer observation periods should be considered for a certain groups of patients with COVID‐19.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.

AUTHOR CONTRIBUTIONS

All authors have agreed on the final version and meet the major criteria recommended by the ICMJE (http://www.icmje.org/). Supporting information Click here for additional data file.
  7 in total

1.  Positive RT-PCR Test Results in Patients Recovered From COVID-19.

Authors:  Lan Lan; Dan Xu; Guangming Ye; Chen Xia; Shaokang Wang; Yirong Li; Haibo Xu
Journal:  JAMA       Date:  2020-04-21       Impact factor: 56.272

2.  SARS to novel coronavirus - old lessons and new lessons.

Authors:  Brian McCloskey; David L Heymann
Journal:  Epidemiol Infect       Date:  2020-02-05       Impact factor: 2.451

3.  SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standards for discharge.

Authors:  Jing-Feng Zhang; Kun Yan; Hong-Hua Ye; Jie Lin; Jian-Jun Zheng; Ting Cai
Journal:  Int J Infect Dis       Date:  2020-03-19       Impact factor: 3.623

4.  Profile of specific antibodies to SARS-CoV-2: The first report.

Authors:  Ai Tang Xiao; Chun Gao; Sheng Zhang
Journal:  J Infect       Date:  2020-03-21       Impact factor: 6.072

5.  Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.

Authors:  Yafang Li; Lin Yao; Jiawei Li; Lei Chen; Yiyan Song; Zhifang Cai; Chunhua Yang
Journal:  J Med Virol       Date:  2020-04-05       Impact factor: 2.327

6.  Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China.

Authors:  Zhanwei Du; Lin Wang; Simon Cauchemez; Xiaoke Xu; Xianwen Wang; Benjamin J Cowling; Lauren Ancel Meyers
Journal:  Emerg Infect Dis       Date:  2020-05-17       Impact factor: 6.883

7.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

  7 in total
  201 in total

Review 1.  Opportunities and Challenges for Biosensors and Nanoscale Analytical Tools for Pandemics: COVID-19.

Authors:  Nikhil Bhalla; Yuwei Pan; Zhugen Yang; Amir Farokh Payam
Journal:  ACS Nano       Date:  2020-06-26       Impact factor: 15.881

Review 2.  Microfluidic-based approaches for COVID-19 diagnosis.

Authors:  Hsuan-Yu Mu; Yu-Lun Lu; Tzu-Hung Hsiao; Jen-Huang Huang
Journal:  Biomicrofluidics       Date:  2020-12-08       Impact factor: 2.800

Review 3.  Laboratory Tests for COVID-19: A Review of Peer-Reviewed Publications and Implications for Clinical UIse.

Authors:  Daniel Shyu; James Dorroh; Caleb Holtmeyer; Detlef Ritter; Anandhi Upendran; Raghuraman Kannan; Dima Dandachi; Christian Rojas-Moreno; Stevan P Whitt; Hariharan Regunath
Journal:  Mo Med       Date:  2020 May-Jun

Review 4.  Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.

Authors:  Nicole Baumgarth; Janko Nikolich-Žugich; F Eun-Hyung Lee; Deepta Bhattacharya
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

5.  Antibiotic Choice: The Synergistic Effect of Single vs Dual Antibiotics.

Authors:  Nequesha S Mohamed; Wayne A Wilkie; Ethan A Remily; James Nace; Ronald E Delanois; James A Browne
Journal:  J Arthroplasty       Date:  2020-03       Impact factor: 4.757

6.  SARS-CoV-2 and rhinovirus/enterovirus co-infection in a critically ill young adult patient in Colombia

Authors:  Juan Pablo Orozco-Hernández; Juan José Montoya-Martínez; Manuel Conrado Pacheco-Gallego; Mauricio Céspedes-Roncancio; Gloria Liliana Porras-Hurtado
Journal:  Biomedica       Date:  2020-10-30       Impact factor: 0.935

7.  Chest CT study of fifteen COVID-19 patients with positive RT-PCR retest results after discharge.

Authors:  Chenxi Li; Fan Luo; Liqiu Xie; Yueqin Gao; Na Zhang; Bing Wu
Journal:  Quant Imaging Med Surg       Date:  2020-06

8.  CT suggests discharged Covid-19 patients who were retested RT-PCR positive again for SARS-CoV-2 more likely had false negative RT-PCR tests before discharging.

Authors:  Yì Xiáng J Wáng
Journal:  Quant Imaging Med Surg       Date:  2020-06

9.  Association between clinical, laboratory findings and chest CT in COVID-19 in a secondary hospital in Jakarta, Indonesia.

Authors:  Muhammad Hafiz; Aziza Ghanie Icksan; Annisa Dian Harlivasari; Sita Andarini; Febrina Susanti; Merryl Esther Yuliana
Journal:  Germs       Date:  2021-03-15

10.  AI aiding in diagnosing, tracking recovery of COVID-19 using deep learning on Chest CT scans.

Authors:  Maheshwar Kuchana; Amritesh Srivastava; Ronald Das; Justin Mathew; Atul Mishra; Kiran Khatter
Journal:  Multimed Tools Appl       Date:  2020-11-08       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.